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KEY POINTS SUMMARY


We determined post-exercise recovery kinetics of quadriceps muscle oxygen uptake

O2)

measured by near-infrared spectroscopy (NIRS) in humans under conditions of both nonlimiting (HIGH) and limiting (LOW) O2 availability, for comparison with biopsy variables.


The

O2 recovery rate constant in HIGH O2 availability was hypothesized to reflect muscle

oxidative capacity (kHIGH); and the difference in k between HIGH and LOW O2 availability
(∆k) was hypothesized to reflect muscle O2 diffusing capacity.


kHIGH was correlated with phosphorylating oxidative capacity of permeabilized muscle fiber
bundles (r=0.80).



∆k was negatively correlated with capillary density (r=-0.68) of biopsy samples.



NIRS provides non-invasive means of assessing both muscle oxidative and oxygen diffusing
capacity in vivo.
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ABSTRACT
The final steps of the O2 cascade during exercise depend on the product of the microvascular-tointramyocyte PO2 difference and muscle O2 diffusing capacity (DmO2). Non-invasive methods to
determine DmO2 in humans are currently unavailable. Muscle oxygen uptake (

O2) recovery rate

constant (k), measured by near-infrared spectroscopy (NIRS) using intermittent arterial occlusions, is
associated with muscle oxidative capacity in vivo. We reasoned that k would be limited by DmO2
when muscle oxygenation is low (kLOW), and hypothesized that: i) k in well-oxygenated muscle (kHIGH)
is associated with maximal O2 flux in fiber bundles; and ii) ∆k (kHIGH-kLOW) is associated with capillary
density (CD). Vastus lateralis k was measured in 12 participants using NIRS after moderate exercise.
The timing and duration of arterial occlusions were manipulated to maintain tissue saturation index
(TSI) within a 10% range either below (LOW) or above (HIGH) half-maximal desaturation, assessed
during sustained arterial occlusion. Maximal O2 flux in phosphorylating state was 37.7±10.6
pmol·s−1·mg−1 (~5.8 ml·min−1·100g−1). CD ranged 348 to 586 mm-2. kHIGH was greater than kLOW
(3.15±0.45 vs 1.56±0.79 min-1, p<0.001). Maximal O2 flux was correlated with kHIGH (r=0.80,
p=0.002) but not kLOW (r=-0.10, p=0.755). Δk ranged -0.26 to -2.55 min-1, and correlated with CD (r=0.68, p=0.015).

O2 k reflects muscle oxidative capacity only in well-oxygenated muscle. ∆k, the

difference in k between well- and poorly-oxygenated muscle, was associated with CD, a mediator of
DmO2. Assessment of muscle k and ∆k using NIRS provides a non-invasive window on muscle
oxidative and O2 diffusing capacity.

RUNNING TITLE: muscle oxidative and O2 diffusing capacity by NIRS

KEYWORDS:
Recovery kinetics, skeletal muscle, mitochondria, capillary density, biopsy
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INTRODUCTION
The primary source of ATP supply in skeletal muscle during endurance exercise is ADP
phosphorylation coupled to the reduction of O2 (Picard et al., 2016). Two primary resistances, limiting
the maximal conductance of O2 from the atmosphere to the muscle mitochondrion, reside within the
cardiovascular system (i.e., convective O2 transport) and at the muscle capillary-myocyte interface
(i.e., diffusive O2 transport) (Wagner, 1992, 1995, 2000; Richardson et al., 1995a).

The interaction of the maximum rate of convective O2 transport and muscle O2 diffusing capacity
(DmO2) determines the maximal muscle O2 upt e
O2 cascade determining

O2) (Roca et al., 1992), the final steps of the

O2 depend on the product of the transmembrane PO2 gradient

(microvascular (mv) to intramyocyte (im) PO2) and the muscle diffusing capacity for O2 (DmO2)
Fic ’s l w of diffusion):

O2 = DmO2 × (PmvO2 – PimO2)

Eq. 1

where (PmvO2 – PimO2) is strongly dependent on convective O2 delivery and muscle O2 demand (as a
function of power output). This results in PimO2 becoming essentially constant at ~1-5 mmHg during
exercise above ~50% maximum O2 upt e

O2max) (Richardson et al., 1995b; Clanton et al., 2013).

DmO2, on the other hand, is a complex function of muscle capillarity, the surface area of apposition of
red blood cells to capillary endothelium, red blood cell capillary transit time, haemoglobin volume,
and the O2 solubility properties within the diffusion pathway (Honig et al., 1984; Groebe & Thews,
1986; Bebout et al., 1993; Wagner, 1995; Poole et al., 2020). Notwithstanding these confounding
variables, DmO2 is related to capillary density (CD; the number of capillaries per summed muscle
fiber cross-sectional area) (Saltin & Gollnick, 1983; Hepple et al., 2000; Poole et al., 2020, 2021,
2022). The observed linear relationship between estimated PmvO2 and
that DmO2 is a major limiting variable for

O2max supports the concept

O2max in humans (Roca et al., 1992; Richardson et al.,

1999). Methods to estimate DmO2 in humans in vivo are complex and previous attempts on
quadriceps muscle required invasive procedures with repeated exercise tests using breathing of gas
mixtures containing high and low fractions of inspired O2. Another approach, using non-invasive
venous occlusion plethysmography to assess capillarity filtration (Brown et al., 2001) provides an
indirect estimation of limb capillarity, but is sensitive to changes in oncotic pressure, endothelial tight
junctions and influenced by all tissues within the limb, not only muscle (Hunt et al., 2013).
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We sought to simplify assessment of DmO2 in human quadriceps using a more muscle specific
approach. We reasoned that, if we could make non-invasive measurements of m O2 under two
different (PmvO2 – PimO2) conditions (i.e. HIGH and LOW), we would be able to solve for DmO2 by
simultaneous subtraction of the two unknowns

O2 and PmvO2, respectively) in Eq. 1, assuming,

as in Roca et al. (1992), that PimO2 is negligible. Near-infrared spectroscopy (NIRS) provides a
relatively simple and non-invasive means to estimate muscle oxidative capacity (Grassi & Quaresima,
2016; Hamaoka & McCully, 2019). The recovery rate constant of

O2 (k) established from the rate

of decline in muscle tissue saturation index (TSI) under serial, intermittent, arterial occlusions
(Hamaoka et al., 1996; Motobe et al., 2004; Ryan et al., 2012; Adami et al., 2017; Adami & Rossiter,
2018) shows good agreement with estimates of muscle oxidative capacity by other techniques e.g.,
phosphocreatine recovery time constant (r = 0.88 – 0.95) (Ryan et al., 2013) or respiratory rates in
fiber bundles (r = 0.61 – 0.74) (Ryan et al., 2014).

We modified the NIRS-based assessment of

O2 by manipulating the timing and duration of the

intermittent arterial occlusions, thereby controlling the mean (PmvO2 – PimO2) at, separately, both
HIGH (non-O2 limiting) and LOW (O2 limiting) values following moderate exercise. More
specifically, we used k s proxy for

O2 and TSI as a proxy of PmvO2. Although not without

li it tions, this ppro ch led us to solve the Fic ’s l w of diffusion s follows:

k = DmO2 × TSI

where PimO2 is considered negligible.
Then, we calculated k for both HIGH (kHIGH) and low (kLOW) TSI values and we compared the k values
with variables obtained from biopsy taken from the same muscle location and individuals. We
hypothesized that the recovery r te const nt of

O2 in high TSI conditions (kHIGH) is associated with

muscle oxidative capacity assessed using high resolution respirometry of permeabilized muscle fiber
bundles.
Finally, we estimated DmO2 from the difference in k values obtained in HIGH and LOW conditions
Δk = kHIGH – kLOW) nd by c lcul ting ΔTSI, ccording to the following equation:
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Δk / ΔTSI = D O2 ~ CD

We then tested the hypothesis th t the difference in the recovery r te const nt of

O2 between

HIGH and LOW TSI conditions (Δk) is associated with capillary density (CD) from biopsy histology.

MATERIALS AND METHODS
Subjects
Twelve moderately trained male (n = 7) and female (n = 5) adult participants (age 28 ± 5 yrs; weight
64.3 ± 10.2 kg; height 173 ± 7 cm) were recruited from the local community. All participants
completed a health history questionnaire to ensure there was no presence of chronic disease. None of
the participants took any medications known to alter metabolism. Participants were fully informed
about the aims, methods, and risks, and gave their written informed consent prior to enrollment. All
procedures were in accordance with the Declaration of Helsinki and the study was approved by the
local ethics committee (Besta 64-19/07/2019).

Study Design
Participants visited the laboratory on four non-consecutive days over a 2-wk period (Fig. 1). They
were instructed to abstain from strenuous physical activity for at least 24 h prior to each testing
session (48 h for the biopsy trial). At visit 1, anthropometric measurements were taken, and an
incremental cardiopulmonary exercise test to the limit of tolerance was administered on an
electronically braked cycle ergometer (LC-6, Monark, Sweden) to determine

O2peak and gas

exchange threshold (GET). At visits 2 and 3, participants performed repeated muscle oxidative
capacity tests within HIGH or LOW muscle oxygenation conditions (2 repeats at each visit),
immediately after 5 min constant work-rate cycling at 80% GET (Zuccarelli et al., 2020). At visit 4,
approximately 100 mg of skeletal muscle was obtained from the vastus lateralis muscle by
percutaneous conchotome muscle biopsy under local anesthesia (1% lidocaine) for muscle
respirometry and morphology.

Incremental exercise
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Power during step-incremental cycling was increased 10-15 W every minute, depending on the
individual’s fitness. Participants were instructed to maintain constant cadence at their preferred value
(between 70 and 85 rpm). Intolerance was defined when participants could no longer maintain their
chosen pedaling frequency despite verbal encouragement. Pulmonary gas exchange and ventilatory
variables were determined breath-by-breath using a metabolic cart (Vyntus CPX, Vyaire Medical
GmbH, Germany), which was c libr ted following the

nuf cturer’s instructions before each test.

HR was recorded by using a chest band (HRM-Dual, Garmin, Kansas, USA), and rating of perceived
exertion (RPE) was determined using Borg® 6–20 scale (Borg, 1982). At rest, and at 1, 3, and 5 min
of recovery, 20 μL of c pill ry blood w s obt ined fro

prehe ted e rlobe for blood l ct te

concentration (Biosen C-line, EKF, Germany). Peak cardiopulmonary variables were measured from
the highest 20 s mean values prior to intolerance. GET was determined by two independent
investigators by using the modified “ -slope”

ethod (Beaver et al., 1986). The power at GET was

estimated after accounting for the individual’s O2 mean response time (Whipp et al., 1981).

Muscle Oxygen Uptake Recovery Rate Constant by NIRS
The m O2 recovery k was measured using an approach modified from Zuccarelli et al. (Zuccarelli et
al., 2020). Oxygenation changes of the vastus lateralis were sampled at 10Hz by a wireless, portable,
continuous-wave, spatially-resolved, NIRS device (PortaLite, Artinis, The Netherlands). Briefly, this
device is equipped with three fiber optic bundles: NIR light is emitted from three optodes at two
wavelengths (760 nm and 850 nm) and received from a fourth optode for transmission back to the
data acquisition unit to determine the relative concentrations of deoxy- and oxy-genated heme groups
contained in hemoglobin (Hb) and myoglobin (Mb). This method does not distinguish between the
contributions of Hb and Mb to the NIRS signal, but Mb signal was assumed to be of minor impact
compared to the contribution of Hb (Grassi & Quaresima, 2016). Relative concentrations of deoxy(hemoglobin+myoglobin) Δ[deoxy(Hb+Mb)]) and oxy-(hemoglobin+myoglobin) (Δ[oxy(Hb+Mb)]
were measured in the tissues approximately 1.5 – 2 cm beneath the probe, with respect to an initial
value obtained at rest before any procedure arbitrarily set equal to zero. From these measurements,
relative changes in total hemoglobin and myoglobin (Δ[tot(Hb+Mb)] = Δ[oxy(Hb+Mb)] +
Δ[deoxy(Hb+Mb)]) and the Hb difference (Δ[diff(Hb+Mb)] = Δ[oxy(Hb+Mb)] – Δ[deoxy(Hb+Mb)])
were calculated. In addition, the tissue saturation index (TSI, %) was measured using the spatiallyresolved spectroscopy (SRS) approach (Ferrari et al., 2004).

The skin at the NIRS probe site was shaved before the probe was placed longitudinally on the lower
third of vastus lateralis muscle (~10 cm above the knee joint), and secured with a black patch and
This article is protected by copyright. All rights reserved.

elastic bandage. The location of the probe was marked using a skin marker to ensure the placement
location was similar across all visits. The mean thickness of the skin and subcutaneous tissue at the
NIRS probe site (7.8 ± 3.1 mm) was measured by skinfold caliper (Holtain Ltd, Crymych, UK). A 13
× 85 cm rapid-inflation pressure-cuff (SC12D, Hokanson, USA) was placed proximally on the same
thigh and attached to an electronically-controlled rapid cuff-inflator (E20, Hokanson, USA).

While participants were seated on a cycle ergometer, baseline TSI and Δ[tot(Hb+Mb)] were measured
over 2 min of rest. Subsequently, a prolonged arterial occlusion (300 mmHg) was performed until TSI
plateaued (typically ~120 s). The cuff was instantly deflated and muscle reoxygenation was recorded
until a steady-state was reached (typically ~3 min). This procedure identified the physiological
normalization (PN) of TSI which was standardized to 0% at the deflection point (TSI min) and 100%
at the maximum value reached during reperfusion (TSI max) (Adami et al., 2017) (Fig. 1).
Participants then cycled for 5 min at a target of 80% GET, followed by an immediate stop and 10-20
intermittent arterial occlusions at 300 mmHg. Duration and timing of the repeated occlusions were
controlled by the investigator to maintain TSI in two different ranges: from 0 to 10% of PN (LOW)
and from 50 to 60% of PN (HIGH), where the total amplitude of PN was used as 0-100% reference
range (Fig. 1). The HIGH range was selected to ensure that occlusions were performed under well
oxygenated conditions, and to avoid the reduction in PO2 could limit m O2 (i.e. maintaining TSI
above 50% of the physiological normalization) (Haseler et al., 2004, Adami & Rossiter, 2018). The
LOW range was selected as the lowest boundary to evaluate m O2 recovery k in poorly-oxygenated
conditions, without overstepping the deflection point (i.e., where TSI during occlusions loses
linearity). On the same day two repetitions of repeated occlusions protocol, separated by a resting
period (typically ~5 min), were performed in a randomized order for both the LOW and HIGH
experimental conditions.

The rate of muscle desaturation during each intermittent arterial occlusion (TSI, %·s−1) was fitted to
estimate the exponential m O2 recovery or k, as previously described (Adami et al., 2017) (Fig. 2).
Data were quality-checked before curve fitting to remove invalid values or outliers i.e., low initial TSI
values, or incomplete occlusions (Beever et al., 2020). The test-retest variability of k was first
assessed. Subsequently k within each condition (kHIGH and kLOW) was calculated from the mean of the
two repeated measurements, and the difference between these conditions was calculated (Δk = kHIGH.kLOW). Δ[tot(Hb+Mb)] above rest was measured during the arterial occlusions of both HIGH and LOW
conditions.
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Muscle Biopsy
Resting muscle biopsies were taken from the vastus lateralis muscle using a 130 mm (6”) WeilBlakesley rongeur (NDB-2, Fehling Instruments, GmbH&Co, Germany) under local anesthesia (1%
lidocaine). After collection, muscle samples were cleaned of excess blood, fat, and connective tissue
in ice-cold BioPS, a biopsy-preserving solution containing (in mM) 2.77 CaK2EGTA, 7.23 K2EGTA,
5.77 Na2ATP, 6.56 MgCl2, 20 taurine, 50 MES (2-(N-morpholino)ethanesulfonic acid), 15
Na2phosphocreatine, 20 imidazole, and 0.5 dithiothreitol adjusted to pH 7.1 (Doerrier et al., 2018). A
portion of each muscle sample (~10-20 mg) was immediately placed in BioPS plus 10% (w/v) fatty
acid free bovine serum albumin (BSA) and 30% (v/v) dimethyl sulfoxide (DMSO) and quickly frozen
in liquid nitrogen; subsequently this portion was stored at -80°C for measurements of mitochondrial
respiration within one month (Kuznetsov et al., 2003). The remaining portion were fixed in OTC
(Tissue-Tek, Sakura Finetek Europe, Zoeterwoude, The Netherlands) embedding medium, frozen in
N2-cooled isopentane and stored at -80°C for subsequent histology.

Preparation of Permeabilized Fibers
Fiber bundles were quickly thawed at room temperature by immersion in BioPS containing 2 mg·ml-1
BSA to remove any residual DMSO from the tissue (Kuznetsov et al., 2003; Wüst et al., 2012). Fibers
were mechanically separated with pointed forceps in ice-cold BioPS under magnification (70×)
(Stereomicroscope CRYSTAL-PRO, Konus-optical & sports systems, Italy). The plasma membrane
was permeabilized by gentle agitation for 30 min at 4°C in 2 ml of BioPS containing 50 µg·ml-1
saponin, washed for 10 min in 2 ml of MiR06 (MiR05 + catalase 280 IU.ml-1) (in mM, unless
specified) 0.5 EGTA, 3 MgCl2, 60 potassium lactobionate, 20 taurine, 10 KH2PO4, 20 HEPES (4-(2hydroxyethyl)piperazine-1-ethanesulfonic acid), 110 sucrose, and 1 g·L-1 BSA, essentially fatty acid–
free (pH 7.1) (Doerrier et al., 2018) and blotted prior to being weighed.

Mitochondrial Respiration
Mitochondrial respiration was measured in duplicate or triplicate, using 3-6 mg wet weight of muscle
fibers, in 2ml of MiR06 at 37°C containing myosin II-ATP se inhibitor 25μM blebbist tin dissolved
in DMSO 5mM stock) to inhibit contraction (Perry et al., 2011) (Oxygraph-2k, Oroboros, Innsbruck,
Austria). Chamber O2 concentration was maintained between 250 and 450 nmol·ml-1 (average O2
partial pressure 250 mmHg) to avoid O2 limitation of respiration. Intermittent reoxygenation steps
were performed during the experiments by injections of 1-3 μl of 0.3
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M H2O2, which was

instantaneously dismutated by catalase, already present in the medium, to O2 and H2O. Instruments
were calibrated according to the

nuf cturer’s instructions (Pesta & Gnaiger, 2012).

A substrate-uncoupler-inhibitor titration protocol was used (Salvadego et al., 2016, 2018; Doerrier et
al., 2018) in the following order: glutamate (10 mM) and malate (4 mM) was added to assess LEAK
respiration through complex I (CIL). ADP (10 mM) was added to assess maximal oxidative
phosphorylation (OXPHOS) capacity through CI (CIP). Succinate (10 mM) was added to assess
OXPHOS capacity through CI + complex II (CI+IIP). Cytochrome c (10 µM) added to test for outer
mitochondrial

membrane

integrity.

Stepwise

additions

of

carbonyl

cyanide-p

trifluoromethoxyphenylhydrazone (FCCP) (0.5 – 1.5 µM) were used to measure electron transport
system capacity through CI+II (CI+IIE). Inhibition of CI by rotenone (1 µM) determined electron
transport system capacity through CII (CIIE), while addition of antimycin A (2.5 µM) was used to
measure residual oxygen consumption, which was subtracted from all measurements. Results were
expressed in pmol·s-1·mg-1 wet weight calculating mean values of duplicate analyses. At the
conclusion of each experiment, muscle samples were removed from the chamber, immediately frozen
in liquid nitrogen and then stored at -80°C until measurement of CS activity.

Citrate Synthase Activity
Muscle samples were thawed and underwent a motor-driven homogenization in a pre-cooled 1 mL
glass-glass potter (Wheaton, USA). The muscle specimen was suspended 1:50 w/v in a
homogenization buffer containing sucrose (250 mM), Tris (20 mM), KCl (40 mM) and EGTA (2
mM) with 1:50 v/v protease (P8340-Sigma) inhibitors. The specimen was homogenized in an ice-bath
with 20 strokes at 500 rpm; before the last hit Triton X-100 (0.1% v/v) was added to the solution.
After this, the sample was left in ice for 30 min. The homogenate was centrifuged at 14,000 g for 10
min. The supernatant was used to evaluate protein concentration according to the method of Lowry et
al. (1951) (Lowry et al., 1951). Protein extracts (5–10–15 μg) were added to each well of a 96-wellmicroplate along with 100 μl of 200

M Tris, 20 μl of 1 mM 5, 5’-dithiobis-2-nitrobenzoate (DTNB),

freshly prepared, 6 μl of 10 M acetyl-coenzyme A (Acetyl-Co-A) and mQ water to a final volume of
190 μl. A b c ground ΔAbs, to detect any endogenous activity by acetylase enzymes, was recorded
for 90 s with 10 s intervals at 412 nm at 25°C by an EnSpire 2300 Multilabel Reader (PerkinElmer).
The ΔAbs was subtracted from the one given after the addition of 10 μl of 10 mM oxalacetic acid that
started the reaction. All assays were performed at 25°C in triplicate on homogenates. Activity was
expressed as nmol·min–1 (mU) per mg of protein. This protocol was modified from (Srere, 1969;
Spinazzi et al., 2012).
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Cross-Sectional Area (CSA) Analysis
Muscle fiber CSA w s deter ined fro

sever l tr nsverse sections 10 μ

thic ) obt ined fro

muscle samples and probed with anti-Dystrophin antibody. Fluorescence images were visualized with
Olympus microscope (U-CMAD3). Fiber CSA was measured with Image J analysis software (NIH,
Bethesda, MD, USA) and expressed in square micrometers. 125 to 150 fibers per sample were
measured.

Capillarization
Several transverse 10 µm sections were obtained from muscle samples mounted in OTC. Sections
were collected at – 20-22°C on the surface of a polarized glass slide. Cryosections were fixed with
methanol in ice for 15 min, washed 3 times (5 min each) in PBS (NaCl 136mM, KCl 2mM, Na2HPO4
6mM, KH2PO4 1mM) at room temperature (RT) and incubated in 1%Triton-100x in PBS for 30 min
(RT). Cryosections were then incubated with blocking reagents (4% BSA in 1% Triton X-100 in PBS
+ 5% Goat Serum) for 30 min (RT), raised with PBS (3 times of 5 min each) and probed with antiCD31 (1:100 dilution, Abcam) overnight at 4°C. After 3 washes (5 min each) in PBS, cryosections
were incubated with Alexa-Fluor 488 anti-mouse (1:200 dilution; Abcam) for 60 min at room
temperature. Finally, the samples were probed with anti-Dystrophin (1:500 dilution, Abcam) for 60
min at room temperature and then with Alexa-Fluor 488 anti-rabbit (1:200 dilution; Abcam) for 60
min at room temperature. Fluorescence intensity was visualized with Olympus microscope (UCMAD3). 125 to 150 fibers were measured in each sample. Capillary density was defined as total
number of capillaries per cross-sectional area of the associated muscle fibers (Hoppeler et al., 1981;
Mathieu-Costello et al., 1988, 1991, 1992; Hepple et al., 2000).

Statistical Analysis
Results are mean ± SD. Normal distribution was verified with Shapiro–Wilk test, nd p ired Student’s
t-test was used to compare differences between two means. p < 0.05 was considered significant. To
assess within-subject test–retest reliability, Pearson coefficient (r), coefficient of variation (CV) and
intraclass correlation coefficient (ICC) were calculated for k measurements performed on different
days. Correlation between respirometry variables and k was performed to compare ex vivo and in vivo
estimates of muscle oxidative capacity. Correl tion between CD nd Δk was performed to examine
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the validity of NIRS to estimate DmO2. Correlation analyses were expressed as Pearson coefficient
(r). Prism 8.0 (GraphPad) was used for data analysis.

RESULTS
Incremental Exercise
O2peak was 37.1 ± 8.0 ml·min−1·kg−1 (range, 22.0 – 50.2 ml·min−1·kg−1) at 214 ± 52 W. Peak heart
rate was 192 ± 9 beats.min-1, approximately 102% of the age-predicted maximum value. RER was
1.28 ± 0.08; [La]b was 11.27 ± 2.24 mmol·l−1, and RPE was 19 ± 1. GET was 1.73 ± 0.41 l·min−1
(69% of O2peak), corresponding to 129 ± 34 W.

Muscle Oxygen Uptake Recovery Rate Constant by NIRS
A total of 48 m O2 recovery kinetics assessments were performed (24 in each of HIGH and LOW
conditions) fter 5- in

oder te intensity exercises 87

26 W). Aver ge

O2 from last 60 s of

exercise was 1.43 ± 0.38 l·min−1 and RER was 0.95 ± 0.03. At the end of exercise RPE was 10 ± 2
and [La]b was 1.47 ± 0.39 mmol·l−1. During last 20 s of cycling quadriceps TSI averaged 62.7 ± 3.9%
(corresponding to 50.4 ± 6.4% of PN).

kHIGH was 3.15 ± 0.45 min-1 and 2.79 ± 0.55 min-1 for the first and second repeat respectively (range
1.88 - 4.01 min-1). kHIGH was not different between repeats (p = 0.1057). kLOW was 1.56 ± 0.79 min-1
and 1.53 ± 0.57 min-1 for first and second repeat, respectively (range 0.38 - 2.65 min-1). kLOW was not
different between repeats (p = 0.9299). Coefficient of variation for repeated measurements was 26%
and 12% for LOW and HIGH, respectively. In all participants and each repeat, kHIGH was greater than
kLOW (both p < 0.001). The individual test-retest reliability of kHIGH and kLOW, assessed on different
days, was good (r = 0.67, p < 0.001; ICC = 0.68, CV = 19%) (Fig. 3). Having established
reproducibility, the mean k for each condition was calculated for comparison with biopsy variables.
Mean kHIGH was 2.97 ± 0.36 min-1 and mean kLOW was 1.54 ± 0.55 min-1. Δk ranged from 0.26 to 2.55
min-1 with a mean value of 1.42 ± 0.69 min-1. Immediately before the first cycling exercise,
Δ[tot(Hb+Mb)] was 3.14 ± 0.77 µM and increased to 9.57 ± 4.52 µM and 11.20 ± 4.05 µM during
arterial occlusions in HIGH and LOW respectively. During arterial occlusions, Δ[tot(Hb+Mb)] was
significantly greater than rest (p = 0.007 and p = 0.002 for HIGH and LOW, respectively).
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Muscle Mitochondrial Respiration and Capillarization
Measurements of mitochondrial O2 flux in permeabilized muscle fibers are shown in Table 1.
Maximal O2 flux in phosphorylating state (CI+IIP) was 37.7 ± 10.6 pmol·s−1·mg−1 (corresponding to
5.8 ml·min−1·100g−1) and maximal uncoupled O2 flux (CI+IIE) was 56.8 ± 19.8 pmol·s−1·mg−1
(corresponding to 8.8 ml·min−1·100g−1). CS activity was 74.3 ± 50.9 mU·mg−1 protein.

Two typical images of CD capillary density measurement are shown in Figure 4. Mean fiber CSA,
fiber number and capillary number in each sample were 5083 ± 73 µm-2, 134 ± 47 and 311 ± 108,
respectively. CD was 469 ± 73 mm-2, ranging from 348 to 586 mm-2 among individuals.

Correlations
kHIGH was correlated with CI+IIP (r = 0.80, p < 0.01) and CI+IIE (r = 0.81, p < 0.01). kLOW was not
correlated with either CI+IIP or CI+IIE (r = -0.10 and r = -0.11, respectively) (Fig 5A-B). Δk was
significantly correlated with capillary density (r = -0.68, p = 0.015) (Fig. 5C).

DISCUSSION
This study tested the hypotheses th t

O2 k is associated with muscle oxidative capacity only in

high TSI conditions and that the difference in

O2 k between well-oxygenated and poorly-

oxygenated muscle provides insight into DmO2. Our data confirmed previous findings (Ryan et al.,
2014) that, in well-oxygenated tissue,

O2 recovery rate constant measured by NIRS, kHIGH, is

correlated with maximal muscle O2 flux in fiber bundles. Additionally, we showed for the first time
that this relationship did not hold when tissue oxygenation was reduced below 50% of the
physiological normalization; and, kLOW was not associated with any variable describing muscle O2 flux
in fiber bundles. This finding is consistent with Fic ’s l w in th t

O2 becomes increasingly

dependent on DmO2 as microvascular-to-myocyte PO2 difference is reduced (see Eq. 1). From this,
we demonstrated that Δk, the difference between kHIGH and kLOW, was associated with capillary density
C:F in biopsy samples of the same tissue, a primary structural determinant of DmO 2. Thus, the NIRSderived response measured under conditions of both well-oxygenated and poorly-oxygenated skeletal
muscle provided a non-invasive means of assessing both muscle oxidative capacity and muscle
diffusing capacity in vivo. The application of this NIRS protocol may be of great interest for the study
of skeletal muscle oxidative and diffusing capacities in response to exercise training or in disease
states (e.g., heart failure, chronic obstructive pulmonary disease, myopathies).
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NIRS and muscle oxidative capacity
In health, skeletal muscle oxidative capacity is strongly correlated with whole-body aerobic capacity
and exercise performance (Holloszy, 1967; Hoppeler et al., 1985; Hood et al., 2011). Moreover,
muscle oxidative capacity and mitochondrial function are impaired in conditions of physical inactivity
(Buso et al., 2019; Zuccarelli et al., 2021), aging (Layec et al., 2013) and chronic disease, such as
obesity (Menshikova et al., 2005; Lazzer et al., 2013), diabetes (Joseph et al., 2012) myopathy
(Grassi et al., 2019, 2020), pulmonary obstructive disease (Adami et al., 2017, 2020), and
neuromuscular disease (Breuer et al., 2013). Traditionally, muscle oxidative capacity has been studied
using ex vivo approaches involving muscle biopsy samples and measurement of enzyme activity, or
mitochondrial respiratory capacity in isolated mitochondrial preparations and permeabilized muscle
fibers (Chance & Williams, 1955; Holloszy, 1967; Gnaiger, 2009; Brand & Nicholls, 2011; Perry et
al., 2013). For a long time, in vivo approaches were limited to

31
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spectroscopy ( P-MRS) to measure the recovery rate of phosphocreatine (PCr) after exercise, which
is associated with maximal O2 flux in muscle (Kemp et al., 1993; Blei et al., 1993; Kent & Fitzgerald,
2016). Over the past decade, however, NIRS coupled with intermittent arterial occlusions, has proven
a valuable tool to assess the

O2 recovery rate constant, k, which is directly associated with muscle

oxidative capacity (Hamaoka et al., 1996; Motobe et al., 2004; Ryan et al., 2012; Grassi &
Quaresima, 2016; Adami et al., 2017; Adami & Rossiter, 2018; Hamaoka & McCully, 2019). The
estimation of muscle oxidative capacity using NIRS has been already examined in upper and lower
limb muscles and in both healthy subjects and patients affected by chronic diseases (Meyer, 1988;
Erickson et al., 2013, 2015; Ryan et al., 2013, 2014; Harp et al., 2016; Adami et al., 2017;
Willingham & McCully, 2017). However, muscle oxidative capacity estimation by NIRS relies on
two main assumptions (Adami & Rossiter, 2018; Chung et al., 2018): i) muscle contractions are
sufficient to maximally activate mitochondrial oxidative enzymes, and ii) O2 concentration at skeletal
muscle level is not a limiting factor to oxidative phosphorylation. Regarding the first point, it has been
demonstrated that the first-order relationship between PCr dynamics and ATP production by oxidative
phosphorylation is valid only when mitochondrial oxidative enzymes are maximal activated.
Additionally, experiments on isolated single frog muscle fibers show that maximal activation of
mitochondrial enzymes may not be achieved when muscle stimulation (or contraction frequency) is
too low (Wüst et al., 2013). For this reason, we used 5 min of moderate intensity cycling to stimulate
OXPHOS and activate a wide range of regulated enzymes within the mitochondrial matrix, with the
goal to reach a high, ideally, maximal mitochondrial activation. Our data for kHIGH show a good
correlation with maximal O2 flux in biopsy samples (either phosphorylating or uncoupled), consistent
with the findings of others. These data confirm that NIRS provides a reasonable non-invasive estimate
of muscle oxidative capacity when the tissue is well-oxygenated.
This article is protected by copyright. All rights reserved.

The second assumption, that O2 concentration is not limiting in the NIRS test, has received relatively
less attention. Bec use

O2 depends in part on the O2 pressure difference between the

microvasculature and the inner mitochondrial membrane in the myocyte to facilitate O2 diffusion, it
stands to reason that reducing PmvO2 could reduce O2 flux nd li it
confirmed previously by the reduction in

O2 k. This suggestion was

O2max and PCr recovery rate constant under conditions of

reduced PmvO2 imposed by breathing hypoxic gas mixtures (Haseler et al., 1999, 2004; Richardson et
al., 1999). By reducing (PmvO2 – PimO2) in hypoxi ,

O2 becomes increasingly dependent on

DmO2 (Eq. 1). Despite this, no study to date investigated whether NIRS-derived

O2 k estimation is

affected by changes in O2 availability. We investigated the reliability and validity of NIRS-derived
O2 k to reflect muscle oxidative capacity under conditions of well- and poorly-oxygenated muscle.
As expected, kHIGH was associated with maximal O2 flux in fiber bundles performed in a hyperoxic
environment (i.e. in non-limiting O2 availability), when TSI was maintained above 50% of PN (r =
0.80 to 0.81; Fig 5A) and showed good reproducibility (test-retest r = 0.67, ICC = 0.68, Fig. 3). The
regression coefficient between methods was very similar to that observed by Ryan et al. (2014) (Ryan
et al., 2014). However, our data also show that this association was lost (r = -0.11 to -0.10) when the
arterial occlusion protocol was experimentally manipulated to hold TSI between 0-10% PN. In the
kLOW condition, good test-retest reproducibility was maintained, but the association with maximal O2
flux by tissue respirometry was absent (Fig. 5B).

The two NIRS tests assessed the same muscle region in tests applied a few minutes apart, therefore
differences between kHIGH and kLOW could not reasonably reflect structural or functional properties in
the skeletal muscle mitochondria. Rather, the difference reflects the increasing importance of DmO2
in kLOW, when (PmvO2 - PimO2) was reduced by experimental manipulation of the occlusion protocol.
Thus,

O2 k is only valid method to estimate muscle oxidative capacity when assessed as kHIGH i.e.,

above 50% PN (Adami & Rossiter, 2018).

NIRS and muscle O2 diffusion
As previously described,

O2 is dependent on the interplay between both convective and diffusive

transport (Roca et al., 1992). In our protocol, we estimated muscle oxidative capacity from the TSI
slope during repeated arterial occlusions, which minimizes the effects of O2 delivery on the estimation
of muscle oxidative capacity. Moreover, we effectively manipulated arterial occlusions such that the
sum of (PmvO2 - PimO2) was either large or small, in the HIGH and LOW conditions respectively. In
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these conditions, convective O2 transport may have an influence on our surrogate measure of DmO2
by modifying capillary Hb volume, RBC transit time, or RBCs immediately adjacent to active muscle
fibers during the reperfusion phase between two occlusions. However, the absence of differences in
Δ[tot(Hb+Mb)] between HIGH and LOW supports the notion that, under these strictly controlled
experimental conditions, convective O2 tr nsport did not influence

y

e suring

O2 k.

O2 under these two conditions we could simultaneously solve by elimination for

DmO2 (Eq. 1). Using NIRS the absolute value of (PmvO2 - PimO2) is unknown; rather the ranges of
TSI used reflected two relative oxygenation values (i.e., HIGH and LOW). Also, bsolute v lues of
O2 are not precisely known using NIRS, although they may be estimated assuming values for
tissue [Hb+Mb] (among other assumptions). Nevertheless, the NIRS-based protocol we used allows
for relative measurement of

O2 and (PmvO2 - PimO2), such that solving Eq. 1 for a relative

estimate of DmO2 is possible. We used the k v lue for
demonstrated kHIGH reflects
unrelated to bsolute
bsolute

O2, r ther th n

O2 itself, because as

uscle oxid tive c p city nd bec use the inetics

O2 are agnostic

e sure ents thereby reducing potenti l v ri bility introduced by co p ring

O2 values from NIRS). Assessment of DmO2 was performed by capillary density and the

finding that Δk was correlated with CD (Fig. 5C) supports the validity of NIRS-based protocol to
estimate DmO2.

Although CD C:F does not assess length and diameter of vessels, the measurement of capillary
density in a muscle cross section may provide information to understand the O2 diffusing capacity of
skeletal muscle (Saltin & Gollnick, 1983; Hepple et al., 2000; Poole et al., 2020, 2021, 2022). Our
CD values ranged from 348 to 586 mm-2, in line with published data (Poole et al., 2020). On the other
hand, Δk ranged more widely from 0.26 to 2.55 min-1. This is presumably because Δk is also
influenced by muscle oxidative capacity, therefore changes in Δk under fixed TSI conditions may
vary more widely than capillary structure alone. Nevertheless, the finding of a significant association
between Δk and CD may allow a valid non-invasive estimation of CD in vivo.

The ability to measure O2 dynamics in microvessels in human skeletal muscles is currently beyond
reach (Koga et al., 2014; Lundby & Montero, 2015). Previous studies have attempted this by
measuring structural components related to the path through plasma and capillary wall to the
cytoplasm (e.g. capillary density) or calculating the ratio of

O2 and O2 pressure gradient between

microvessels and mitochondria using the method developed by Wagner and colleagues (Roca et al.,
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1989, 1992; Richardson et al., 1999; Hepple et al., 2000). Although these elegant experiments were
fundamental to move forward knowledge in the field, they do not fully account for the physiological
mechanisms of in vivo regulation and reduce a complex diffusion process to a few key variables
(Hepple et al., 2000).

A step towards a more physiological approach was used by Brown et al. (Brown et al., 2001). In
endurance and resistance trained athletes, Brown et al. estimated capillary filtration capacity with
plethysmography during small incremental steps in venous occlusion pressure. They found an
association between filtration capacity and muscle capillarity, consistent with a relationship between
capillary filtration and capillary surface area (Brown et al., 2001; Hunt et al., 2013). In our study we
used NIRS to follow the flux of O2 rather than fluid within the capillary-to-myofiber. In addition,
NIRS is able to estimate changes in Δ[tot(Hb+Mb)] within the microvasculature, such that our NIRSbased method likely more closely reflects apposition of red-blood cells with capillary endothelium
and therefore the O2 diffusion pathway. The action of repeated occlusions has the effect of increasing
Δ[tot(Hb+Mb)] in the microvasculature (~10 µM in Δ[tot(Hb+Mb)] from rest which should account
for an increase in hematocrit of ~18%, leading to a total hematocrit of 33%), thereby generating a
diffusional surface area that may be closer to in vivo condition when DmO2 is maximized i.e., high
longitudinal capillary recruitment at approach exercise at maximal aerobic capacity. That NIRS
measures the oxygenation of all [Hb+Mb] within the field of view, may therefore, be a more valid
reflection the final steps in O2 cascade than structural properties of the capillaries alone. However, as
yet undeveloped, more advanced techniques are needed to test this hypothesis.

The correlation coefficients of k with muscle oxidative capacity and Δk with CD were relatively small
when compared with correlations for clinical techniques (Hanneman, 2008). However, the Pearson
correlation coefficient resulting in our study (r = 0.80 and r = -0.68, respectively) was similar with
other validation studies comparing in vivo methods with ex vivo approaches using NIRS (r = 0.61 –
0.74) (Ryan et al., 2014). While NIRS and biopsy were taken from the same muscle region, the
volumes assayed by each of these techniques are different (~2-3 cm3 and ~1 mm3, respectively). In
addition, the structural and functional assessments differ between NIRS and biopsy. Unlike NIRS,
maximal O2 flux in fiber bundles in respirometry is assessed using supraphysiologic concentrations of
substrates, including O2, and reflects all fibers in the sample. Maximal O2 flux based on NIRS signals
derive from only those fibers that were active during the exercise, and therefore may be biased
towards low order fibers (slow, oxidative). As discussed, CD is a structural contributor to DmO2, but
may not reflect to the true capacity for O2 diffusion in tissue with variable capillary content of red
blood cells. Therefore, variability between methods is expected, with the NIRS potentially having the
This article is protected by copyright. All rights reserved.

advantage that it assays a larger muscle volume than the biopsy, and assays under physiologic
conditions in vivo.

CONCLUSIONS
In summary, we report reliability and accuracy of NIRS measurements of

O2 during intermittent

arterial occlusions protocols to estimate muscle oxidative capacity and muscle DmO2 in vivo. The
O2 recovery rate constant, k, was a reasonable and reliable method to assess muscle oxidative
capacity only when assessed in well-oxygenated quadriceps muscle (>50% of TSI physiological
normalization). Experimental manipulation of TSI through timing and duration of intermittent arterial
occlusions provided a new variable, Δk, which was the difference in k between well-oxygenated and
poorly-oxygenated experimental conditions. As hypothesized, we found that Δk was associated with
CD, a structural determinant of DmO2. Therefore, the NIRS-based protocol we describe represents a
cost-effective and non-invasive means of assessing both muscle oxidative capacity and muscle O2
diffusive capacity in vivo.

DATA AVAILABILITY STATEMENT
All relevant data are presented as individual data points in the figures. Data not presented with
individual data points are available from the corresponding author upon request.
ACKNOWLEDGEMENTS
The authors would like to acknowledge the participants who joined the project and graduate students
Andrea Alberti and Andrea Colombo for their help during data recording.
DISCLOSURES
Simone Porcelli was supported by a grant from Sports Medicine Italian Federation (FMSI01092021).
Alessandra Adami is supported by a grant from NIH (R01HL151452). Harry Rossiter is supported by
grants from NIH (R01HL151452, R01HL153460, P50HD098593, R01DK122767, P2CHD086851),
the Tobacco Related Disease Research Program (T31IP1666), and the University of California, Office
of the President. He reports consulting fees from Omniox Inc., and is involved in contracted clinical
research with Boehringer Ingelheim, GlaxoSmithKline, Novartis, AstraZeneca, Astellas, United
Therapeutics, Genentech and Regeneron. He is a visiting Professor at the University of Leeds, UK.

This article is protected by copyright. All rights reserved.

REFERENCES
Adami A, Cao R, Porszasz J, Casaburi R & Rossiter HB (2017). Reproducibility of NIRS assessment
of muscle oxidative capacity in smokers with and without COPD. Respir Physiol Neurobiol 235,
18–26.
Adami A, Corvino RB, Calmelat RA, Porszasz J, Casaburi R & Rossiter HB (2020). Muscle
Oxidative Capacity Is Reduced in Both Upper and Lower Limbs in COPD. Med Sci Sports
Exerc 52, 2061–2068.
Adami A & Rossiter HB (2018). Principles, insights, and potential pitfalls of the noninvasive
determination of muscle oxidative capacity by near-infrared spectroscopy. J Appl Physiol 124,
245–248.
Beaver WL, Wasserman K & Whipp BJ (1986). A new method for detecting anaerobic threshold by
gas exchange. J Appl Physiol 60, 2020–2027.
Bebout DE, Hogan MC, Hempleman SC & Wagner PD (1993). Effects of training and immobilization
on VO2 and DO2 in dog gastrocnemius muscle in situ. J Appl Physiol 74, 1697–1703.
Beever AT, Tripp TR, Zhang J & MacInnis MJ (2020). NIRS-derived skeletal muscle oxidative
capacity is correlated with aerobic fitness and independent of sex. J Appl Physiol 129, 558–568.
Blei ML, Conley KE, Odderson IR, Esselman PC & Kushmerick MJ (1993). Individual variation in
contractile cost and recovery in a human skeletal muscle. Proc Natl Acad Sci U S A 90, 7396–
7400.
Borg G (1982). Ratings of Perceived Exertion and Heart Rates During Short-Term Cycle Exercise and
Their Use in a New Cycling Strength Test. Int J Sports Med 3, 153–158.
Brand MD & Nicholls DG (2011). Assessing mitochondrial dysfunction in cells. Biochem J 435, 297–
312.
Breuer ME, Koopman WJ, Koene S, Nooteboom M, Rodenburg RJ, Willems PH & Smeitink JAM
(2013). The role of mitochondrial OXPHOS dysfunction in the development of neurologic
diseases. Neurobiol Dis 51, 27–34.
Brown MD, Jeal S, Bryant J & Gamble J (2001). Modifications of microvascular filtration capacity in
human limbs by training and electrical stimulation. Acta Physiol Scand 173, 359–368.
uso A, Co elli M, Picco R, Isol M, M gnes

, Pišot R, Rittweger J, S lv dego D, Ši unič ,

Grassi B & Mavelli I (2019). Mitochondrial adaptations in elderly and young men skeletal

This article is protected by copyright. All rights reserved.

muscle following 2 weeks of bed rest and rehabilitation. Front Physiol; DOI:
10.3389/FPHYS.2019.00474/PDF.
Chance B & Williams GR (1955). Respiratory enzymes in oxidative phosphorylation. IV. The
respiratory chain. J Biol Chem 217, 429–438.
Chung S et al. (2018). Commentaries on Viewpoint: Principles, insights, and potential pitfalls of the
noninvasive determination of muscle oxidative capacity by near-infrared spectroscopy. J Appl
Physiol 124, 254–255.
Clanton TL, Hogan MC & Gladden LB (2013). Regulation of cellular gas exchange, oxygen sensing,
and metabolic control. Compr Physiol 3, 1135–1190.
Doerrier C, Garcia-Souza LF, Krumschnabel G, Wohlfarter Y, Mészáros AT & Gnaiger E (2018).
High-Resolution FluoRespirometry and OXPHOS Protocols for Human Cells, Permeabilized
Fibers from Small Biopsies of Muscle, and Isolated Mitochondria. Methods Mol Biol 1782, 31–
70.
Erickson ML, Ryan TE, Young HJ & McCully KK (2013). Near-infrared assessments of skeletal
muscle oxidative capacity in persons with spinal cord injury. Eur J Appl Physiol 113, 2275–
2283.
Erickson ML, Seigler N, Mckie KT, Mccully KK & Harris RA (2015). Skeletal muscle oxidative
capacity in patients with cystic fibrosis. Exp Physiol 100, 545–552.
Ferrari M, Mottola L & Quaresima V (2004). Principles, techniques, and limitations of near infrared
spectroscopy. Can J Appl Physiol 29, 463–487.
Gnaiger E (2009). Capacity of oxidative phosphorylation in human skeletal muscle New perspectives
of mitochondrial physiology. Int J Biochem Cell Biol 41, 1837–1845.
Grassi B, Porcelli S & Marzorati M (2019). Translational Medicine: Exercise Physiology Applied to
Metabolic Myopathies. Med Sci Sports Exerc 51, 2183–2192.
Grassi B, Porcelli S & M rzor ti M 2020). Met bolic Myop thies: “Hu

n Knoc out” Models nd

Translational Medicine. Front Physiol; DOI: 10.3389/FPHYS.2020.00350/PDF.
Grassi B & Quaresima V (2016). Near-infrared spectroscopy and skeletal muscle oxidative function
in vivo in health and disease: a review from an exercise physiology perspective. J Biomed Opt
21, 091313.
Groebe K & Thews G (1986). Theoretical analysis of oxygen supply to contracted skeletal muscle.

This article is protected by copyright. All rights reserved.

Adv Exp Med Biol 200, 495–514.
Hamaoka T, Iwane H, Shimomitsu T, Katsumura T, Murase N, Nishio S, Osada T, Kurosawa Y &
Chance B (1996). Noninvasive measures of oxidative metabolism on working human muscles
by near-infrared spectroscopy. J Appl Physiol 81, 1410–1417.
Hamaoka T & McCully KK (2019). Review of early development of near-infrared spectroscopy and
recent advancement of studies on muscle oxygenation and oxidative metabolism. J Physiol Sci
69, 799–811.
Hanneman SK (2008). Design, analysis, and interpretation of method-comparison studies. AACN Adv
Crit Care 19, 223–234.
Harp MA, McCully KK, Moldavskiy M & Backus D (2016). Skeletal muscle mitochondrial capacity
in people with multiple sclerosis. Mult Scler J - Exp Transl Clin; DOI:
10.1177/2055217316678020.
Haseler LJ, Hogan MC & Richardson RS (1999). Skeletal muscle phosphocreatine recovery in
exercise-trained humans is dependent on O2 availability. J Appl Physiol 86, 2013–2018.
Haseler LJ, Lin AP & Richardson RS (2004). Skeletal muscle oxidative metabolism in sedentary
humans: 31P-MRS assessment of O2 supply and demand limitations. J Appl Physiol 97, 1077–
1081.
Hepple RT, Hogan MC, Stary C, Bebout DE, Mathieu-Costello O & Wagner PD (2000). Structural
basis of muscle O(2) diffusing capacity: evidence from muscle function in situ. J Appl Physiol
88, 560–566.
Holloszy JO (1967). Biochemical Adaptations in Muscle: Effects of exercise on mitochondrial oxygen
uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 242, 2278–2282.
Honig CR, Gayeski TE, Federspiel W, Clark A & Clark P (1984). Muscle O2 gradients from
hemoglobin to cytochrome: new concepts, new complexities. Adv Exp Med Biol 169, 23–38.
Hood DA, Uguccioni G, Vainshtein A & D’souz D 2011). Mech nis s of exercise-induced
mitochondrial biogenesis in skeletal muscle: implications for health and disease. Compr Physiol
1, 1119–1134.
Hoppeler H, Howald H, Conley K, Lindstedt SL, Claassen H, Vock P & Weibel ER (1985).
Endurance training in humans: aerobic capacity and structure of skeletal muscle. J Appl Physiol
59, 320–327.

This article is protected by copyright. All rights reserved.

Hoppeler H, Mathieu O, Weibel ER, Krauer R, Lindstedt SL & Taylor CR (1981). Design of the
mammalian respiratory system. VIII Capillaries in skeletal muscles. Respir Physiol 44, 129–150.
Hunt JEA, Galea D, Tufft G, Bunce D & Ferguson RA (2013). Time course of regional vascular
adaptations to low load resistance training with blood flow restriction. J Appl Physiol 115, 403–
411.
Joseph AM, Joanisse DR, Baillot RG & Hood DA (2012). Mitochondrial dysregulation in the
pathogenesis of diabetes: potential for mitochondrial biogenesis-mediated interventions. Exp
Diabetes Res; DOI: 10.1155/2012/642038.
Kemp GJ, Taylor DJ & Radda GK (1993). Control of phosphocreatine resynthesis during recovery
from exercise in human skeletal muscle. NMR Biomed 6, 66–72.
Kent JA & Fitzgerald LF (2016). In vivo mitochondrial function in aging skeletal muscle: capacity,
flux, and patterns of use. J Appl Physiol 121, 996–1003.
Koga S, Rossiter HB, Heinonen I, Musch TI & Poole DC (2014). Dynamic heterogeneity of
exercising muscle blood flow and O2 utilization. Med Sci Sports Exerc 46, 860–876.
Kuznetsov A V., Kunz WS, Saks V, Usson Y, Mazat JP, Letellier T, Gellerich FN & Margreiter R
(2003). Cryopreservation of mitochondria and mitochondrial function in cardiac and skeletal
muscle fibers. Anal Biochem 319, 296–303.
Larsen S, Nielsen J, Hansen CN, Nielsen LB, Wibrand F, Stride N, Schroder HD, Boushel R, Helge
JW, Dela F & Hey-Mogensen M (2012). Biomarkers of mitochondrial content in skeletal muscle
of healthy young human subjects. J Physiol 590, 3349–3360.
Layec G, Haseler LJ & Richardson RS (2013). Reduced muscle oxidative capacity is independent of
O2 availability in elderly people. Age (Dordr) 35, 1183–1192.
Lazzer S, Salvadego D, Porcelli S, Rejc E, Agosti F, Sartorio A & Grassi B (2013). Skeletal muscle
oxygen uptake in obese patients: functional evaluation by knee-extension exercise. Eur J Appl
Physiol 113, 2125–2132.
Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951). Protein measurement with the Folin
phenol reagent. J Biol Chem 193, 265–275.
Lundby C & Montero D 2015). CrossT l opposing view: Diffusion li it tion of O2 fro
icrovessels into

uscle does not contribute to the li it tion of O2

3761.

This article is protected by copyright. All rights reserved.

x. J Physiol 593, 3759–

Mathieu-Costello O, Ellis CG, Potter RF, MacDonald IC & Groom AC (1991). Muscle capillary-tofiber perimeter ratio: morphometry. Am J Physiol; DOI:
10.1152/AJPHEART.1991.261.5.H1617.
Mathieu-Costello O, Potter RF, Ellis CG & Groom AC (1988). Capillary configuration and fiber
shortening in muscles of the rat hindlimb: correlation between corrosion casts and stereological
measurements. Microvasc Res 36, 40–55.
Mathieu-Costello O, Suarez RK & Hochachka PW (1992). Capillary-to-fiber geometry and
mitochondrial density in hummingbird flight muscle. Respir Physiol 89, 113–132.
Menshikova E V., Ritov VB, Toledo FGS, Ferrell RE, Goodpaster BH & Kelley DE (2005). Effects
of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am J
Physiol Endocrinol Metab; DOI: 10.1152/AJPENDO.00322.2004.
Meyer RA (1988). A linear model of muscle respiration explains monoexponential phosphocreatine
changes. Am J Physiol; DOI: 10.1152/AJPCELL.1988.254.4.C548.
Motobe M, Murase N, Osada T, Homma T, Ueda C, Nagasawa T, Kitahara A, Ichimura S, Kurosawa
Y, Katsumura T, Hoshika A & Hamaoka T (2004). Noninvasive monitoring of deterioration in
skeletal muscle function with forearm cast immobilization and the prevention of deterioration.
Dyn Med 3, 1–11.
Perry CGR, Kane DA, Lanza IR & Neufer PD (2013). Methods for assessing mitochondrial function
in diabetes. Diabetes 62, 1041–1053.
Perry CGR, Kane DA, Lin C Te, Kozy R, Cathey BL, Lark DS, Kane CL, Brophy PM, Gavin TP,
Anderson EJ & Neufer PD (2011). Inhibiting myosin-ATPase reveals a dynamic range of
mitochondrial respiratory control in skeletal muscle. Biochem J 437, 215–222.
Pesta D & Gnaiger E (2012). High-resolution respirometry: OXPHOS protocols for human cells and
permeabilized fibers from small biopsies of human muscle. Methods Mol Biol 810, 25–58.
Picard M, Wallace DC & Burelle Y (2016). The rise of mitochondria in medicine. Mitochondrion 30,
105–116.
Poole DC, Kano Y, Koga S & Musch TI (2021). August Krogh: Muscle capillary function and oxygen
delivery. Comp Biochem Physiol A Mol Integr Physiol; DOI: 10.1016/J.CBPA.2020.110852.
Poole DC, Musch TI & Colburn TD (2022). Oxygen flux from capillary to mitochondria: integration
of contemporary discoveries. Eur J Appl Physiol 122, 7–28.

This article is protected by copyright. All rights reserved.

Poole DC, Pittman RN, Musch TI & Østerg rd L 2020). August Krogh’s theory of

uscle

microvascular control and oxygen delivery: a paradigm shift based on new data. J Physiol 598,
4473–4507.
Richardson RS, Grassi B, Gavin TP, Haseler LJ, Tagore K, Roca J & Wagner PD (1999). Evidence of
O2 supply-dependent O 2

x) in the exercise-trained human quadriceps. J Appl Physiol 86,

1048–1053.
Richardson RS, Knight DR, Poole DC, Kurdak SS, Hogan MC, Grassi B & Wagner PD (1995a).
Determinants of maximal exercise VO2 during single leg knee-extensor exercise in humans. Am
J Physiol; DOI: 10.1152/AJPHEART.1995.268.4.H1453.
Richardson RS, Noyszewski EA, Kendrick KF, Leigh JS & Wagner PD (1995b). Myoglobin O2
desaturation during exercise. Evidence of limited O2 transport. J Clin Invest 96, 1916–1926.
Roca J, Agusti AGN, Alonso A, Poole DC, Viegas C, Barbera JA, Rodriguez-Roisin R, Ferrer A &
Wagner PD (1992). Effects of training on muscle O2 transport at VO2max. J Appl Physiol 73,
1067–1076.
Roca J, Hogan MC, Story D, Bebout DE, Haab P, Gonzalez R, Ueno O & Wagner PD (1989).
Evidence for tissue diffusion limitation of VO2max in normal humans. J Appl Physiol 67, 291–
299.
Ryan TE, Brophy P, Lin C Te, Hickner RC & Neufer PD (2014). Assessment of in vivo skeletal
muscle mitochondrial respiratory capacity in humans by near-infrared spectroscopy: a
comparison with in situ measurements. J Physiol 592, 3231–3241.
Ryan TE, Erickson ML, Brizendine JT, Young HJ & McCully KK (2012). Noninvasive evaluation of
skeletal muscle mitochondrial capacity with near-infrared spectroscopy: correcting for blood
volume changes. J Appl Physiol 113, 175–183.
Ryan TE, Southern WM, Reynolds MA & McCully KK (2013). A cross-validation of near-infrared
spectroscopy measurements of skeletal muscle oxidative capacity with phosphorus magnetic
resonance spectroscopy. J Appl Physiol 115, 1757–1766.
Saltin B & Gollnick PD (1983). Skeletal Muscle Adaptability: Significance for Metabolism and
Performance. Compr Physiol555–631.
Salvadego D, Keramidas ME, Brocca L, Domenis R, Mavelli I, Rittweger J, Eiken O, Mekjavic IB &
Grassi B (2016). Separate and combined effects of a 10-d exposure to hypoxia and inactivity on
oxidative function in vivo and mitochondrial respiration ex vivo in humans. J Appl Physiol 121,

This article is protected by copyright. All rights reserved.

154–163.
Salvadego D, Keramidas ME, Kölegård R, Brocca L, Lazzer S, Mavelli I, Rittweger J, Eiken O,
Mekjavic IB & Grassi B (2018). PlanHab*: hypoxia does not worsen the impairment of skeletal
muscle oxidative function induced by bed rest alone. J Physiol 596, 3341–3355.
Spinazzi M, Casarin A, Pertegato V, Salviati L & Angelini C (2012). Assessment of mitochondrial
respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc 7, 1235–1246.
Srere PA (1969). Citrate synthase: EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)]. Methods
Enzymol 13, 3–11.
Wagner PD (1992). Gas exchange and peripheral diffusion limitation. Med Sci Sports Exerc 24, 54–
58.
Wagner PD (1995). Limitations of oxygen transport to the cell Background and present knowledge.
Intensive Care Med 21, 391–398.
Wagner PD (2000). Diffusive resistance to O2 transport in muscle. Acta Physiol Scand 168, 609–614.
Whipp BJ, Davis JA, Torres F & Wasserman K (1981). A test to determine parameters of aerobic
function during exercise. J Appl Physiol 50, 217–221.
Willingham TB & McCully KK (2017). In vivo assessment of mitochondrial dysfunction in clinical
populations using near-infrared spectroscopy. Front Physiol; DOI:
10.3389/FPHYS.2017.00689/PDF.
Wüst RCI, van der Laarse WJ & Rossiter HB (2013). On-off asymmetries in oxygen consumption
kinetics of single Xenopus laevis skeletal muscle fibres suggest higher-order control. J Physiol
591, 731–744.
Wüst RCI, Myers DS, Stones R, Benoist D, Robinson PA, Boyle JP, Peers C, White E & Rossiter HB
(2012). Regional skeletal muscle remodeling and mitochondrial dysfunction in right ventricular
heart failure. Am J Physiol Heart Circ Physiol; DOI: 10.1152/AJPHEART.00653.2011.
Zuccarelli L, Baldassarre G, Magnesa B, Degano C, Comelli M, Gasparini M, Manferdelli G,
M rzor ti M, M velli I, Pilotto A, Porcelli S, R sic L, Ši unič , Pišot R, N rici M & Gr ssi
B (2021). Peripheral impairments of oxidative metabolism after a 10-day bed rest are upstream
of mitochondrial respiration. J Physiol 599, 4813–4829.
ucc relli L, Do N sci ento S lv dor PC, Del Torto A, Fiorentino R & Gr ssi
uscle o 2 inetics by the NIRS repe ted occlusions
ergometer exercise. J Appl Physiol 128, 534–544.

This article is protected by copyright. All rights reserved.

2020). S elet l

ethod during the recovery fro

cycle

Figure 1. Study design and muscle recovery rate constant (k) protocol by NIRS
P rticip nts visited the l bor tory on 4 occ sions.
O2peak) and gas exchange threshold GET).
nor

isit 1 w s used to deter ine pe

oxygen upt e

isits 2 nd 3 were used to deter ine the physiologic l

liz tion PN) of qu driceps TSI following sust ined rteri l occlusion, nd the

uscle

O2

recovery rate constant (k) in well-oxygenated (HIGH) and poorly-oxygenated (LOW) conditions. Two
k measurements were performed at each visit. To measure k, participants initially cycled for 5 min at
80% GET, followed immediately by 10-20 intermittent arterial occlusions (300 mmHg). The duration
and timing of repeated occlusions were modulated in order to maintain TSI in two different ranges:
from 0 to 10% of PN (LOW) and from 50 to 60% of PN (HIGH). A muscle biopsy was obtained in
visit 4.
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Figure 2. Representative tissue saturation index (TSI) responses during repeated arterial
occlusions of the quadriceps following moderate exercise in LOW and HIGH conditions.
Represent tive

uscle TSI profiles nd

O2 recovery kinetics during intermittent arterial occlusions

following 5 min moderate intensity cycling. A) TSI profile in poorly-oxygenated (LOW; TSI = 0-10%
of physiological normalization) condition. B) TSI profile in well-oxygenated (TSI = 50-60% of
physiological normalization) condition. C)
calculation of kLOW. D)

O2 recovery and exponential fit (black line) for

O2 recovery and exponential fit (black line) for calculation of kHIGH. Grey

point represents outlier, excluded from the analysis (see methods). k is the recovery rate constant. n=1.
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Figure 3. Individual test-retest reliability of muscle oxidative capacity by NIRS
The individual test-retest reliability of recovery rate constant (k) assessed by NIRS in different days
during both HIGH (black circles) and LOW (grey circles) on 12 participants. Straight line represents
linear regression curve and dashed line represent 95% confidence intervals. Grey line represents
identity. Circles represent k values obtained during first and second trial.
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Figure 4. Muscle capillarization from two participants.
Immunofluorescent identification of capillaries in cross sections of vastus lateralis from two
participants. A) Participant with the highest capillary density. B) Participant with the lowest capillary
density. After immunostaining using anti-CD31, capillaries appear green. (n=2).
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Figure 5. Association between in vivo (NIRS) and ex vivo (biospy) estimation of (A-B) skeletal
muscle OXPHOS capacity and (C) skeletal muscle capillary density.
Correlation between muscle oxidative phosphorylation capacity by high-resolution respirometry and
recovery rate constant by NIRS measured in HIGH (A) and LOW (B) conditions. C) Correlation
between Δk (= kHIGH - kLOW) by NIRS nd c pill ry density CD) fro

biopsy. Δk is lower in

participants with a greater muscle capillarization. Linear regression (solid) 95% confidence intervals
(dash). n=12.
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Table 1. Mitochondrial O2 flux in permeabilized muscle fibers
Mass specific

CIL

CIP

CI+IIP

CI+IIE

CIIE

Mean ± SD

6.0 ± 3.2

14.6 ± 5.8

37.7 ± 10.6

56.8 ± 19.8

45.3 ± 14.8

Min

0.0

4.5

23.0

33.6

29.1

Max

11.3

23.9

54.3

99.9

76.6

(pmol·s−1·mg−1)

CIL, leak respiration through CI; CIP, maximum coupled mitochondrial respiration through CI; CI+IIP,
maximum coupled mitochondrial respiration through CI+II; CI+IIE, maximum noncoupled
mitochondrial respiration through CI+II; CIIE, maximum noncoupled mitochondrial respiration
through CII. Mitochondrial respiration was measured in duplicate or triplicate, n=12.
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Abstract figure As for Larsen et al, please delete the reference from the list. GRAPHICAL ABSTRACT
LEGEND NIRS probe was positioned on vastus lateralis muscle and used to assess both muscle
oxidative and oxygen diffusing capacity in vivo by intermittent arterial occlusions. Timing and
duration of each occlusion were manipulated to maintain tissue saturation index (TSI) within a
10percentage range either below (LOW) or above (HIGH) half-maximal desaturation. Recovery rate
constant (k) of muscle oxygen consumption (mV O2) obtained by NIRS was correlated to
phosphorylating oxidative capacity of permeabilized muscle fiber bundles. Changes in recovery rate
constant (k) were correlated to capillary density calculated from cross-section of muscle samples
obtained by immunofluorescence
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